Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Natalia Scaramellini, MD, Carola Arighi, MD, Alessia Marcon, MD, Dario Consonni, MD, Elena Cassinerio, MD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Irene Motta, MD

Blood (2019) 134 (Supplement_1): 3542.

https://doi.org/10.1182/blood-2019-130237

Published: 2019

Journal Articles

Evaluation of Pulmonary Function in Patient with Transfusion Dependent Beta Thalassemia with Severe Iron Overload

Mohamed A Yassin, MBBS, MSc, Mushtaq Ahmad, MD, Shehab Mohamed, MD, Khadra S Yassin, BSC, Abdulqadir Jeprel Nashwan, BSN, MSN, Vincenzo Desanctis, MD PhD, Ashraf Tawfiq Soliman, MD PhD

Blood (2019) 134 (Supplement_1): 4818.

https://doi.org/10.1182/blood-2019-121828

Published: 2019

Journal Articles

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

K. Scott Baker, Wendy M. Leisenring, Pamela J. Goodman, Ralph P. Ermoian, Mary E. Flowers, G. Schoch, Rainer Storb, Brenda M. Sandmaier, H. Joachim Deeg

Blood (2019) 133 (26): 2790–2799.

https://doi.org/10.1182/blood.2018874115

Published: 2019

Includes: Supplemental data

Journal Articles

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Blood (2018) 132 (Supplement 1): 2412.

https://doi.org/10.1182/blood-2018-99-110875

Published: 2018

Journal Articles

Arachidonic Acid Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Cristina Panaroni, PhD, Keertik Fulzele, PhD, Rosemary Soucy, Ka Tat Siu, PhD, Kenta Mukaihara, MD PhD, Cherrie Huang, Shrikanta Chattopadhyay, MBBS, Noopur Raje, MD

Blood (2018) 132 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2018-99-118482

Published: 2018

Journal Articles

Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade ® and Jadenu TM

Justin Keen, PhD, Dave Miller, PhD, Simon Tulloch, BA MA BM BCh

Blood (2017) 130 (Supplement 1): 2215.

https://doi.org/10.1182/blood.V130.Suppl_1.2215.2215

Published: 2017

Journal Articles

Endocrinological Abnormalities Among Adult Thallasemic Patients

Sule Unal Cangul, Mufide Okay, Ugur Unluturk, Seda B. Oguz, Mualla Cetin, Fatma Gumruk, MD, Nilgun Sayinalp, MD, Inci Bajin

Blood (2017) 130 (Supplement 1): 2218.

https://doi.org/10.1182/blood.V130.Suppl_1.2218.2218

Published: 2017

Journal Articles

Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders

Holly Pacenta, MD, Rebecca Coughlin, Shelby Winzent, PA, Joanne M. Hilden, MD, Dianne Thornhill, PhD, Brian R. Branchford, MD, Kelly Maloney, MD, Nuechterlein Brandon, PA, Amy Keating, MD, Taizo Allen Nakano, MD, Roger Giller, MD, Christopher Michael McKinney, MD

Blood (2017) 130 (Supplement 1): 2099.

https://doi.org/10.1182/blood.V130.Suppl_1.2099.2099

Published: 2017

Journal Articles

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Angela Vitrano, PhD, Massimiliano Sacco, DR, Rosamaria Rosso, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Esther Natalie Oliva, MD, Calogera Gerardi, MD, Gaetano Roccamo, MD, Vincenzo Spadola, MD, Aldo Filosa, MD, Lorenzo Tesé, MD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Laura Mistretta, DR, Filippo Cassarà, DR, Rosario Di Maggio, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 936.

https://doi.org/10.1182/blood.V130.Suppl_1.936.936

Published: 2017

Journal Articles

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Samir K. Ballas, MD, Vu H. Duong, MD, Michelle Deveaux, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 3743.

https://doi.org/10.1182/blood.V130.Suppl_1.3743.3743

Published: 2017

Journal Articles

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Marta Mancarella, MD, Diletta Maira, MD, Valeria Ferla, Marco Capecchi, MD, Irene Motta, MD, Elena Cassinerio, MD, Alessia Marcon, MD, Marina Baldini, MD, Maria Domenica Cappellini, MD

Blood (2016) 128 (22): 4830.

https://doi.org/10.1182/blood.V128.22.4830.4830

Published: 2016

Journal Articles

Adipose Tissue Functions As a Reservoir for Leukemia Stem Cells and Confers Chemo-Resistance

Haobin Ye, Biniam Adane, Nabilah Khan, PhD, John M. Ashton, PhD, Marlene Balys, Brett M Stevens, PhD, Mohammad Minhajuddin, Craig T Jordan, PhD

Blood (2015) 126 (23): 845.

https://doi.org/10.1182/blood.V126.23.845.845

Published: 2015

Journal Articles

Adipocyte-Derived Adiponectin Positively Regulates Exit from Quiescence of Hematopoietic Stem Cells By Potentiating mTORC1 Activation after Myelotoxic Injury

Yosuke Masamoto, MDPhD, Shunya Arai, MD, PhD, Tomohiko Sato, MD PhD, Iseki Takamoto, MD PhD, Naoto Kubota, MD PhD, Takashi Kadowaki, MD PhD, Mineo Kurokawa, MD PhD

Blood (2015) 126 (23): 777.

https://doi.org/10.1182/blood.V126.23.777.777

Published: 2015

Journal Articles

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Niklas Gunnarsson, MD, Martin Hoglund, MD PhD, Leif Stenke, MD PhD, Solveig Wallberg Jonsson, MD PhD, Fredrik Sandin, PhD, Magnus Bjorkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevarn, MD, Ulla Olsson-Stromberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD PhD, Anders Sjalander, MD PhD

Blood (2015) 126 (23): 1586.

https://doi.org/10.1182/blood.V126.23.1586.1586

Published: 2015

Journal Articles

Thalassemia Major and Intermedia in Older Patients – a Single Center Experience

Liat Shargian-Alon, MD, Idit Pazgal, MD, Pia Raanani, MD, Eliezer Rachmilewitz, MD, Pinhas Stark, MD

Blood (2014) 124 (21): 2685.

https://doi.org/10.1182/blood.V124.21.2685.2685

Published: 2014

Journal Articles

Patient and Caregiver Perspectives of Factors Associated with Adherence to and Satisfaction with Iron Chelation Therapy

Vasudha Bal, MSc, MBA, Isabelle Cote, PhD, Kathryn Lasch, PhD MA, MSSW, BA, Vicky Huang, MS

Blood (2014) 124 (21): 2166.

https://doi.org/10.1182/blood.V124.21.2166.2166

Published: 2014

Journal Articles

Long Term Efficacy Of Iron Chelation Therapy With Deferasirox On Endocrine Function In Thalassemia Major

Maddalena Casale, MD, Serena Citarella, MD, Aldo Filosa, MD, Elisa De Michele, Umberto Pugliese, MD, Palmieri Francesco, Alfonso Ragozzino, MD, Amendola Giovanni, MD, Immacolata Tartaglione, MD, Milena Della Rocca, MD, Bruno Nobili, MD, Perrotta Silverio, MD

Blood (2013) 122 (21): 965.

https://doi.org/10.1182/blood.V122.21.965.965

Published: 2013

Journal Articles

The Bone Marrow Hematopoietic Microenvironment Is Functionally Impaired in Iron-Overloaded Mice,

Hiroshi Okabe, Takahiro Suzuki, Eisuke Uehara, Masuzu Ueda, Tadashi Nagai, MD, PhD, Keiya Ozawa, M.D, Ph.D

Blood (2011) 118 (21): 3173.

https://doi.org/10.1182/blood.V118.21.3173.3173

Published: 2011

Journal Articles

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Rodolfo Cancado, Maria Cristina Olivato, Paula Bruniera, Murilo Rezende Melo, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 5148.

https://doi.org/10.1182/blood.V116.21.5148.5148

Published: 2010

Journal Articles

Iron Overload Accelerates Development of Leukaemia: Evidence From a Mouse Model

Lap Shu Alan Chan, MSc, Lilly Chunhong Gu, MD, PhD, Michael J. Rauh, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2010) 116 (21): 122.

https://doi.org/10.1182/blood.V116.21.122.122

Published: 2010

NARROW

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Evaluation of Pulmonary Function in Patient with Transfusion Dependent Beta Thalassemia with Severe Iron Overload

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Arachidonic Acid Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade ® and Jadenu TM

Endocrinological Abnormalities Among Adult Thallasemic Patients

Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Adipose Tissue Functions As a Reservoir for Leukemia Stem Cells and Confers Chemo-Resistance

Adipocyte-Derived Adiponectin Positively Regulates Exit from Quiescence of Hematopoietic Stem Cells By Potentiating mTORC1 Activation after Myelotoxic Injury

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Thalassemia Major and Intermedia in Older Patients – a Single Center Experience

Patient and Caregiver Perspectives of Factors Associated with Adherence to and Satisfaction with Iron Chelation Therapy

Long Term Efficacy Of Iron Chelation Therapy With Deferasirox On Endocrine Function In Thalassemia Major

The Bone Marrow Hematopoietic Microenvironment Is Functionally Impaired in Iron-Overloaded Mice,

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Iron Overload Accelerates Development of Leukaemia: Evidence From a Mouse Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only